Precision BioSciences, Inc. (DTIL)
NASDAQ: DTIL · Real-Time Price · USD
3.900
-0.230 (-5.57%)
Jan 15, 2026, 4:00 PM EST - Market closed
Precision BioSciences Market Cap
Precision BioSciences has a market cap or net worth of $93.88 million as of January 15, 2026. Its market cap has increased by 163.19% in one year.
Market Cap
93.88M
Enterprise Value
77.66M
1-Year Change
163.19%
Ranking
Category
Stock Price
$3.90
Market Cap Chart
Since March 28, 2019, Precision BioSciences's market cap has decreased from $855.07M to $93.88M, a decrease of -89.02%. That is a compound annual growth rate of -27.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 14, 2026 | 99.42M | -0.72% |
| Dec 31, 2025 | 100.14M | 242.63% |
| Dec 31, 2024 | 29.23M | -34.32% |
| Dec 29, 2023 | 44.50M | -66.30% |
| Dec 30, 2022 | 132.04M | -70.64% |
| Dec 31, 2021 | 449.68M | 2.74% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 28, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 961.00B |
| Johnson & Johnson | 526.55B |
| AbbVie | 392.16B |
| UnitedHealth Group | 303.42B |
| AstraZeneca | 299.25B |
| Novartis AG | 278.73B |
| Merck & Co. | 275.53B |
| Novo Nordisk | 262.20B |